Second-line chemotherapy versus supportive cancer treatment in advanced gastric cancer: a meta-analysis HS Kim, HJ Kim, SY Kim, TY Kim, KW Lee, SK Baek, MH Ryu, BH Nam, ... Annals of Oncology 24 (11), 2850-2854, 2013 | 156 | 2013 |
Prognostic value of KRAS mutation in advanced non-small-cell lung cancer treated with immune checkpoint inhibitors: A meta-analysis and review JH Kim, HS Kim, BJ Kim Oncotarget 8 (29), 48248, 2017 | 118 | 2017 |
Helicobacter pylori Eradication in Idiopathic Thrombocytopenic Purpura: A Meta‐Analysis of Randomized Trials BJ Kim, HS Kim, HJ Jang, JH Kim Gastroenterology research and practice 2018 (1), 6090878, 2018 | 78 | 2018 |
Prognostic value of smoking status in non-small-cell lung cancer patients treated with immune checkpoint inhibitors: a meta-analysis JH Kim, HS Kim, BJ Kim Oncotarget 8 (54), 93149, 2017 | 71 | 2017 |
A randomised, double-blind, placebo-controlled multi-centre phase III trial of XELIRI/FOLFIRI plus simvastatin for patients with metastatic colorectal cancer SH Lim, TW Kim, YS Hong, SW Han, KH Lee, HJ Kang, IG Hwang, JY Lee, ... British journal of cancer 113 (10), 1421-1426, 2015 | 71 | 2015 |
Prognostic and predictive value of VHL gene alteration in renal cell carcinoma: a meta-analysis and review BJ Kim, JH Kim, HS Kim, DY Zang Oncotarget 8 (8), 13979, 2017 | 69 | 2017 |
Chemotherapy in elderly patients with gastric cancer HS Kim, JH Kim, JW Kim, BC Kim Journal of Cancer 7 (1), 88, 2016 | 63 | 2016 |
Excision repair cross‐complementation group 1 (ERCC1) expression in advanced urothelial carcinoma patients receiving cisplatin‐based chemotherapy KH Kim, INGU DO, HS Kim, MH Chang, HS Kim, HJ Jun, J Uhm, SY Yi, ... Apmis 118 (12), 941-948, 2010 | 56 | 2010 |
Comparison of RECIST version 1.0 and 1.1 in assessment of tumor response by computed tomography in advanced gastric cancer GS Jang, MJ Kim, HI Ha, JH Kim, HS Kim, SB Ju, DY Zang Chinese Journal of Cancer Research 25 (6), 689, 2013 | 51 | 2013 |
Docetaxel, gemcitabine, and cisplatin administered for non-small cell lung cancer during the first and second trimester of an unrecognized pregnancy JH Kim, HS Kim, CW Sung, KJ Kim, CH Kim, KY Lee Lung cancer 59 (2), 270-273, 2008 | 51 | 2008 |
Prognostic impact of TTF-1 expression in non-squamous non-small-cell lung cancer: a meta-analysis JH Kim, HS Kim, BJ Kim, B Han, DR Choi, JH Kwon Journal of Cancer 9 (22), 4279, 2018 | 50 | 2018 |
Effect of supplementation of Bacillus subtilis LS 1-2 grown on citrus-juice waste and corn-soybean meal substrate on growth performance, nutrient retention, caecal microbiology … S Sen, SL Ingale, JS Kim, KH Kim, YW Kim, C Khong, JD Lohakare, ... Asian-Australasian journal of animal sciences 24 (8), 1120-1127, 2011 | 48 | 2011 |
The addition of bevacizumab in the first-line treatment for metastatic colorectal cancer: an updated meta-analysis of randomized trials HJ Jang, BJ Kim, JH Kim, HS Kim Oncotarget 8 (42), 73009, 2017 | 44 | 2017 |
Clinical comparisons of two free light chain assays to immunofixation electrophoresis for detecting monoclonal gammopathy HS Kim, HS Kim, KS Shin, W Song, HJ Kim, HS Kim, MJ Park BioMed research international 2014 (1), 647238, 2014 | 44 | 2014 |
Clinical features and prognostic factors of patients with “peripheral T cell lymphoma, unspecified” Y Lee, JE Uhm, HY Lee, MJ Park, H Kim, SJ Oh, JH Jang, K Kim, ... Annals of hematology 88, 111-119, 2009 | 44 | 2009 |
Prognostic value of c-Met overexpression in hepatocellular carcinoma: a meta-analysis and review JH Kim, HS Kim, BJ Kim, HJ Jang, J Lee Oncotarget 8 (52), 90351, 2017 | 39 | 2017 |
Clinical impact of phosphorylated signal transducer and activator of transcription 3, epidermal growth factor receptor, p53, and vascular endothelial growth factor receptor 1 … HS Kim, YH Park, J Lee, JS Ahn, J Kim, YM Shim, JH Kim, K Park, J Han, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2010 | 39 | 2010 |
Pathological and prognostic impacts of FGFR2 overexpression in gastric cancer: a meta-analysis HS Kim, JH Kim, HJ Jang, B Han, DY Zang Journal of Cancer 10 (1), 20, 2019 | 37 | 2019 |
Clinicopathologic Significance of VHL Gene Alteration in Clear-Cell Renal Cell Carcinoma: An Updated Meta-Analysis and Review HS Kim, JH Kim, HJ Jang, B Han, DY Zang International journal of molecular sciences 19 (9), 2529, 2018 | 34 | 2018 |
Prognostic value of MET copy number gain in non-small-cell lung cancer: an updated meta-analysis JH Kim, HS Kim, BJ Kim Journal of Cancer 9 (10), 1836, 2018 | 32 | 2018 |